Observational studyCancer medicine2023

Prior irinotecan exposure does not preclude benefit to liposomal irinotecan in patients with metastatic pancreatic ductal adenocarcinoma.

Kenneth H Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.